Cibc Private Wealth Group, LLC Charles River Laboratories International, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 15,466 shares of CRL stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,466
Previous 13,597
13.75%
Holding current value
$2.18 Million
Previous $2.51 Million
7.29%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$862 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$718 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$605 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$338 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$275 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.18B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...